Perelel is a technology company.
Perelel has raised $11.0M across 2 funding rounds.
Perelel has raised $11.0M in total across 2 funding rounds.
The premise of your query is incorrect: Perelel is not a technology company—it is a women's health supplement company.[1][2][3]
Perelel is a doctor-founded, research-backed supplement company that provides targeted vitamins and nutritional products for women across different stages of their hormonal lifecycle.[3] The company serves women navigating fertility, pregnancy, postpartum recovery, perimenopause, and menstrual cycle health by offering clinically-formulated vitamin packs designed with bioavailable ingredients tested for purity and safety.[2]
The core problem Perelel solves is the fragmentation and lack of scientific rigor in women's vitamins. As co-founder Alex Taylor noted, "The women's health category is at a breaking point with influencer-led brands and unproven product claims."[3] Perelel differentiates itself by grounding its products in clinical expertise and robust research rather than marketing hype.
The company has demonstrated strong growth momentum: it achieved profitability within five years of founding, doubled revenue year-over-year, and maintains category-leading subscriber retention rates.[3] In November 2025, Perelel secured a $27 million growth investment from Prelude Growth Partners, marking its evolution from a prenatal-focused brand to a comprehensive women's health company.[3]
Perelel was founded in 2020 by Victoria Thain Gioia, Alex Taylor, and Dr. Banafsheh Bayati, an OB/GYN who serves as the company's medical co-founder.[3][5] The idea emerged from personal frustration: Victoria was sourcing vitamins from multiple sources and sorting through pills and bottles each morning—an inefficient, expensive, and unsustainable approach.[5] When Victoria and Alex compared notes with other women, they realized the vitamin industry was fundamentally broken: it was underregulated, lacked transparent ingredient information, and offered oversimplified products that didn't account for women's changing hormonal needs.[5]
With Dr. Bayati's medical expertise, the founders set out to create stage-specific vitamin routines using bioavailable, research-backed ingredients in clinically-tested doses, delivered in simple daily packs.[5] The company is based in Los Angeles, California.[2]
Perelel operates within a rapidly consolidating women's health ecosystem. The company recently acquired Loom, a women's sexual health education platform, in October 2024, signaling expansion beyond supplements into holistic women's wellness.[2] This mirrors broader consolidation trends in sexual wellness startups, where companies like Dame and Hello Cake are acquiring complementary brands to build comprehensive platforms.
The timing is significant: women's health has become a venture-backed category as investors recognize underserved markets and the credibility gap in women's nutrition. Perelel's success—achieving profitability and attracting institutional growth capital—validates that science-backed, clinically-rigorous approaches resonate with consumers fatigued by unsubstantiated wellness claims.
Perelel is positioned to become a category leader in clinical women's health nutrition by leveraging its doctor-founded credibility in an increasingly crowded market. The $27 million growth round signals investor confidence in scaling beyond prenatal vitamins into a full-lifecycle women's health brand.
The company's next chapter likely involves deepening its product portfolio (evidenced by the Loom acquisition), expanding international operations, and potentially building a broader wellness ecosystem that combines supplements, education, and telehealth services. As consumer skepticism toward unproven wellness claims grows, Perelel's commitment to clinical rigor and transparency will likely become a competitive moat—transforming it from a niche prenatal brand into a trusted partner for women's health across all life stages.
Perelel has raised $11.0M in total across 2 funding rounds.
Perelel's investors include Verity Venture Partners, Willow Growth Partners LP, M13, Bill Ackman.
Perelel has raised $11.0M across 2 funding rounds. Most recently, it raised $6.0M Series A in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2024 | $6.0M Series A | Verity Venture Partners, Willow Growth Partners LP | |
| Jul 1, 2022 | $5.0M Seed | M13, Bill Ackman |